Skip to content
TrustList
Xeraya Capital cover

About Xeraya Capital

The company announced changes to its senior management team to support its commercialization execution Read more

Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter

Acutus' flagship product now certified under the new European Medical Device Regulations Read more

Foghorn Therapeutics Highlights Recent Clinical and Research Progress

Also announced strategic objectives for 2023 Read more

Championing

collaborations that improve health and the quality of life for everyone.

WHAT'S TRENDING @ XERAYA

Foghorn® Highlights Recent Clinical & Research Progress

ARE YOU

The Next Big Thing?

Categories & features

Ask TrustList to introduce you to Xeraya Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Xeraya Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Xeraya Capital.

Xeraya Capital alternatives

Similar listings buyers compare against this one.